Buprenorphine in Neonatal Abstinence Syndrome-Reference-Cited by-同舟云学术

Buprenorphine in Neonatal Abstinence Syndrome

Published:2017-11-28 Issue:1 Volume:103 Page:112-119
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Kraft Walter K.¹

Affiliation:

1. Sidney Kimmel Medical College of Thomas Jefferson University, Department of Pharmacology and Experimental Medicine; Philadelphia Pennsylvania USA

Funder

National Institute on Drug Abuse

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference70 articles.

1. Review: the blood-brain barrier; protecting the developing fetal brain;Goasdoue;Placenta,2017

2. Acute neonatal effects of cocaine exposure during pregnancy;Bauer;Arch. Pediatr. Adolesc. Med.,2005

3. The roles of maternal depression, serotonin reuptake inhibitor treatment, and concomitant benzodiazepine use on infant neurobehavioral functioning over the first postnatal month;Salisbury;Am. J. Psychiatry,2016

4. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes;Jones;Drug Alcohol Depend.,2013

5. Food and Drug Administration FDA Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns. https://www.fda.gov/Drugs/DrugSafety/ucm243903.htm 2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal Morphology and Synaptogenic Signaling in Astrocytes Following Prenatal Opioid Exposure;Cells;2024-05-14

2. Abnormal morphology and synaptogenic signaling in astrocytes following prenatal opioid exposure;2024-04-11

3. Evaluating the Impact of Eat, Sleep, Console in Neonatal Abstinence Syndrome Treatment for Infants Exposed to Substance Use In Utero;The Journal of Pediatric Pharmacology and Therapeutics;2024-04-01

4. Forecasting Fetal Buprenorphine Exposure through Maternal–Fetal Physiologically Based Pharmacokinetic Modeling;Pharmaceutics;2024-03-08

5. Stability Study of a Compounded Sublingual Buprenorphine Solution for Neonatal Opioid Withdrawal Syndrome;The Journal of Pediatric Pharmacology and Therapeutics;2023-12-01